logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
I

Idris Bahce

Cancer Treatment and Quality of Life
H指数:31
被引数:4,706

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

In-human assessment of target engagement and blockade of radiolabeled BI 765063, an anti-SIRPα antibody

在人中评估放射性标记的BI 765063（一种抗-SIRPα抗体）的靶点结合和阻断作用

EJNMMI Research
IF3
2026-08-130
OAAI
Johanna E.E. Pouw; Mirte Stavenga; Gerben J.C. Zwezerijnen; Khanum Ridler; Idris Bahce; Kristell Marzin; Neetika Nath; Milena J. Tosiek; Mario Amend; Andrea Thiele; Danielle J. Vugts; Tanja D. de Gruijl; Marc C. Huisman; C. Willemien Menke-van der Houven van Oordt
Statescope: an integrative deconvolution framework for discovering cell states in tumors

Statescope：一种用于在肿瘤中发现细胞状态的整合式解卷积框架

Nature Communications
IF15.7
2026-07-060
OAAI
Jurriaan Janssen; Mischa F. B. Steketee; Aryamaan Bose; Saskia van Asten; Paul P. Eijk; Frederike Dijk; Arantza Farina Sarasqueta; Febe van Maldegem; David P. Noske; Idris Bahce; Jan Koster; Juan J. Garcia Vallejo; Richard Schoonhoven; Mark A. van de Wiel; Teodora Radonic; Bauke Ylstra; Yongsoo Kim
The survival impact of combining radiotherapy and immune checkpoint inhibitors in patients with solid tumors: a systematic review and living meta-analysis of randomized controlled trials.

实体肿瘤患者联合放疗和免疫检查点抑制剂的生存影响：一项随机对照试验的系统评价和实时Meta分析。

European Journal of Cancer
IF7.1
2026-05-250
OAAI
Mathijs L. Tomassen; Claudia E. Pronk; Eric Deutsch; Joost J.C. Verhoeff; Ben J. Slotman; Hanneke W.M. van Laarhoven; Idris Bahce; Abrahim Al-Mamgani; Tanja D. de Gruijl; Suresh Senan; Famke L. Schneiders; Peter S.N. van Rossum
Outcomes of stereotactic ablative radiotherapy or surgery for early-stage lung cancer in patients with interstitial lung disease

间质性肺疾病患者早期肺癌的立体定向消融放射治疗或手术治疗结果

Radiotherapy and Oncology
IF5.3
2026-05-090
OAAI
Mathijs L. Tomassen; Suzan F.M. Nijman; Esther J. Nossent; Iris A. Simons; Chris Dickhoff; Onno M. Mets; Teodora Radonic; Bart G. Boerrigter; Martijn van Dorp; David J. Heineman; Merle I. Ronden Kianoush; Idris Bahce; Cornelis J.A. Haasbeek; Famke L. Schneiders; Joost J.C. Verhoeff; Peter S.N. van Rossum; Suresh Senan
Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group

纳入临床试验的可切除III期非小细胞肺癌（NSCLC）定义：由EORTC肺癌组领导的泛欧洲多学科专家小组的临床病例回顾

Lung Cancer
IF4.4
2025-10-140
PRE
Mariana Brandão; Elena Prisciandaro; Eleni Xenophontos; Alessio Mariolo; Amir H. Sadeghi; Andrea R. Filippi; Antonin Levy; Artur Bandura; Caroline Caramella; Chris Dickhoff; Constance de Margerie-Mellon; Corinne Faivre-Finn; Daniel Portik; David Sanchez-Lorente; Dirk De Ruysscher; Egbert Smit; Elisa Gobbini; Elie Fadel; Enrico Ruffini; Emanuela Olmetto; Francesco Cortiula; Idris Bahce; Ilias Houda; Isabelle Opitz; Jarushka Naidoo; John Edwards; Jordi Remon; José Carlos Benitez; Juan Carlos Trujillo; Jules Derks; Karim Amrane; Koen J. Hartemink; Konstantinos Stathopoulos; Lizza E.L. Hendriks; Manoli Iglesias; Mario Occhipinti; Matthias Guckenberger; Niccolo Giaj Levra; Nicolas Girard; Noemi Reguart; Olaf Mercier; Paolo Bironzo; Paul Hofman; René Horsleben Petersen; Riccardo De Angelis; Ronan Abgral; Safae Terrisse; Sanjay Popat; Thomas Pierret; Torsten Gerriet Blum; Umberto Ricardi; Valeria Dionisi; Thierry Berghmans; Anne-Marie C. Dingemans
Survival outcomes with carboplatin versus cisplatin and the impact of COVID-19 on platinum choice: A nationwide Netherlands registry study in small cell lung cancer patients (CACIS)

卡铂与顺铂的生存结局以及COVID-19对铂类药物选择的影响：一项针对小细胞肺癌患者的荷兰全国登记研究（CACIS）

European Journal of Cancer
IF7.1
2025-10-020
PRE
Ilias Houda; Dwayne Naves; Ezgi Ulas; Birgit I. Lissenberg-Witte; Nicole Barlo; Elisabeth A. Kastelijn; Hicham Bouhaddou; Rimsha Shaikh; Chris Dickhoff; Teodora Radonic; Famke L. Schneiders; Suresh Senan; Ronald A.M. Damhuis; Idris Bahce
89Zr-mAb uptake interpretation requires the use of tissue to plasma ratios corrected for antibody catabolism

89Zr-mAb的摄取解释需要使用校正了抗体分解代谢的组织与血浆比率。

EJNMMI Research
IF3
2025-09-260
OA
Marc C. Huisman; Johanna E. E. Pouw; Sandeep S. V. Golla; Damien Huglo; Franck Morschhauser; Josée M. Zijlstra; Jessica E. Wijngaarden; Mirte Stavenga; Hylke J. Sebus; Maarten Slebe; Andrea Thiele; Danielle Vugts; Iris H. C. Miedema; Gerben J.C. Zwezerijnen; Idris Bahce; C. Willemien Menke-van der Houven van Oordt; Dhaval K. Shah; Yvonne W. S. Jauw; Ronald Boellaard
Cell-Free DNA Based Next-Generation Sequencing Does Not Differentiate Between Oligoprogression and Systemic Progression in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors—An Explorative Study

基于细胞自由DNA的下一代测序无法区分接受免疫检查点抑制剂治疗的非小细胞肺癌患者中的寡进展和全身进展——一项探索性研究

International Journal of Molecular Sciences 2025, Vol. 26, Page 8087
IF4.9
2025-08-210
PRE
Pim Rozendal; Hanneke Kievit; Paul van der Leest; Idris Bahce; Michiel Pegtel; Harry J. M. Groen; Léon C. van Kempen; T. Jeroen N. Hiltermann; Ed Schuuring
Physiologically Based Pharmacokinetic Model of Tyrosine Kinase Inhibitors to Predict Target Site Penetration, with PET-Guided Verification
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY
IF3
2025-02-010
OAAI
van Der Gaag, Suzanne; Jordens, Tamara; Yaqub, Maqsood; Grijseels, Robbin; van Valkengoed, Daan W.; de Langen, Evelien N.; van den Broek, Ruben; Thijssen, Victor L. J. L.; de Langen, Adrianus J.; Kouwenhoven, Mathilde C. M.; Bahce, Idris; Westerman, Bart A.; Hendrikse, N. Harry; Bartelink, Imke H.
Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in patients with resectable and borderline resectable lung cancer: the INCREASE study

ipilimumab加尼武利尤单抗联合放化疗治疗可切除和临界可切除肺癌患者的单臂试验: 增加研究

JOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
2024-09-300
OAAI
Bahce, Idris; Dickhoff, Chris; Schneiders, Famke L.; Veltman, Joris; Heineman, David J.; Hashemi, Sayed M. S.; Vrijmoet, Anne; Houda, Ilias; Ulas, Ezgi B.; Bakker, Joyce; van de Ven, Peter; Bouwhuis, Natalja; Meijboom, Lilian J.; Oprea-Lager, Daniela E.; van Maldegem, Febe; Fransen, Marieke F.; de Gruijl, Tanja D.; Radonic, Teodora; Senan, Suresh
Impact of common germline variants on the toxicity profile and pharmacokinetics of alectinib

共有的胚系变异对阿来替尼毒性特征和药代动力学的影响

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Heersche, N.; Lanser, D. A. C.; Muntinghe, B.; Ali, M. I. Mohmaed; Ulas, E. B.; Trooster, T. M. A.; de Jonge, E.; Oomen-de Hoop, E.; Paats, M. S.; Bahce, I.; Croes, S.; Hendriks, L. E.; Van der Wekken, A. J.; Dingemans, A-M. C.; Huitema, A. D. R.; Van Schaik, R.; Mathijssen, R. H.; Veerman, M. G. D.

研究方向

暂未获取到该数据
S
Suresh Senan
H 指数:95论文数:831被引数:4.1万
C
Chris Dickhoff
H 指数:21论文数:172被引数:1,559
E
Egbert F. Smit
H 指数:113论文数:1,213被引数:6.0万
R
Ronald Boellaard
H 指数:92论文数:1,023被引数:4.1万
T
Teodora Radonic
H 指数:29论文数:141被引数:3,095
F
Famke L. Schneiders
H 指数:15论文数:92被引数:1,195
S
Sayed M.S. Hashemi
H 指数:23论文数:95被引数:2,212
M
Marc C. Huisman
H 指数:38论文数:231被引数:4,818
I
Ilias Houda
H 指数:10论文数:28被引数:498
E
Ezgi B Ulas
H 指数:5论文数:23被引数:288